Novartis Keeps MSN’s Entresto Copy Off Market During Appeal (1)

May 27, 2025, 2:31 PM UTCUpdated: May 27, 2025, 3:20 PM UTC

Novartis AG blocked MSN Laboratories Pvt. Ltd.’s attempt to launch a copy of its blockbuster Entresto before July 16, as a federal appeals court denied MSN’s request to pause an injunction and fast-track its appeal of a judgment enforcing pediatric exclusivity.

The US Court of Appeals for the Federal Circuit denied MSN’s motion for a stay and to expedite the appeal because the company failed to show it was “likely to succeed in demonstrating that the district court abused its discretion in declining to allow amendment of the complaint to state a delisting counterclaim,” Circuit Judge Timothy B. Dyk wrote ...

Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.